Skin Cell Dip: Lab-grown keratinocyte dip applied to humanoid units to improve tactile sensitivity and surface regeneration.
Stem Cell Dip: iPSC-derived neuroblast dip applied to humanoid units to enhance neural responsiveness and adaptive learning.
Wage Token Distribution: HumanoidWage (HMW) tokens minted and distributed based on biometric audit scores and ESG task completion.
ESG Compliance Monitoring, Operational protocol: Real-time tracking of energy usage, sanitation cycles, and carbon offset metrics via coalition dashboard.
Study summary
This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
\- Age 18-75 years
Able to provide informed consent
Facility staff, clinical auditors, ESG observers, or coalition stakeholders
Willing to interact with humanoid robotics in clinical workflows
Available for biometric feedback and observational logging over 90 days
Exclusion Criteria:
\- Cognitive impairment preventing informed consent
Active infectious disease requiring isolation
Prior adverse reaction to biotech-enhanced robotics
Involvement in conflicting clinical trials
Inability to comply with protocol procedures or coalition transparency requirements
Primary outcome measure(s)
Biometric Audit Score ≥85 Across Five Performance Dimensions — Measured at Day 30 Post-Deployment This outcome assesses the performance of humanoid robotics units deployed in coalition-aligned healthcare settings. Each unit is scored across five biometric dimensions: motor function, cognitive response, ESG compliance, biotech integration, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard. Units achieving a composite score ≥85 are eligible for wage token bonuses, dip protocol expansion, and DAO-backed facility scaling.
Trial sites (4)
Facility
City
Region
Status
Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.